Autolus Limited

This study is testing an experimental treatment called Obe-cel for children and teenagers whose B-cell leukemia or lymphoma has returned or not responded to standard treatments. Doctors will collect the patient's own immune cells, genetically modify them to better target cancer c…

This program provides access to a personalized cell therapy (obe-cel) for adults with a hard-to-treat form of acute lymphoblastic leukemia (ALL). It is for patients whose own manufactured therapy batch did not meet the usual quality standards for commercial use and who cannot saf…

This is an early-stage safety study testing a new cell therapy called obe-cel in adults with a progressive form of multiple sclerosis that hasn't responded to other treatments. The main goal is to see if the treatment is safe and what side effects it might cause, while also looki…

This early study is testing a new treatment for severe lupus that hasn't responded to other therapies. Doctors take a patient's own immune cells, modify them to target lupus-causing cells, and return them to the body. The study will check if this approach is safe and shows early …